Paris cohort (n = 212) | BIODEGMAR cohort (n =175 ) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CU Aβ− | MCI Aβ− | Dementia Aβ− | MCI Aβ+ | Dementia Aβ+ | P-value | CU Aβ− | MCI Aβ− | Dementia Aβ− | CU Aβ+ | MCI Aβ+ | Dementia Aβ+ | P-value | |
n = 21 | n = 47 | n = 27 | n = 40 | n = 77 | n=11 | n=28 | n=19 | n=7 | n=46 | n=64 | |||
Age, years | 64.6 (9.42) | 66.30 (9.58) | 66.04 (7.73) | 72.40 (7.96)a | 71.90 (8.61)a | < 0.0001 | 70.4 (5.8) | 71.4 (6.1) | 70.0 (6.1) | 70.1 (4.5) | 74.4 (4.8) | 73.5 (4.5) | 0.009 |
Male (% male) | 8 (38%) | 16 (34%) | 15 (56%) | 16 (40%) | 30 (39%) | 0.338 | 3 (27%) | 16 (57%) | 6 (32%) | 2 (29%) | 19 (41%) | 25 (39%) | 0.141 |
APOEε4 carriers | 7/21 (33%) | 5/47 (11%)a | 7/26 (27%) | 22/40 (55%) | 51/76 (67%)a | < 0.001 | 1/10 (10%) | 4/24 (17%) | 3/18 (17%) | 3/7 (43%) | 24/38 (63%)a | 39/62 (61%)a | < 0.02 |
Level of education, years | 11.5 (2.4) | 10.7 (2.2) | 11.0 (2.1) | 10.0 (2.5) | 10.6 (2.4) | 0.299 | 10.4 (4.9) | 8.5 (4.6) | 7.75 (4.7) | 11.4 (4.0) | 8.4 (4.6) | 7.7 (3.6) | 0.0267 |
MMSE score | 27.14 (2.45) | 24.00 (4.01)a | 23.85 (4.87)a | 23.82 (3.84)a | 19.09 (5.74)a | < 0.0001 | 28.4 (2.3) | 25.6 (2.7) | 22.2 (5.8)a | 28.7 (1.5) | 23.3 (3.9)a | 20.4 (4.8)a | < 0.0001 |
Core biomarkers Lumipulse | |||||||||||||
CSF Aβ1–42 | 1060.95 (245.23) | 1090.66 (468.75) | 1027.78 (354.02) | 553.00 (209.36)a | 497.88 (155.27)a | < 0.0001 | 1186 (357) | 1164 (549) | 986 (449) | 634 (206)a | 556 (178)a | 522 (153)a | < 0.0001 |
CSF Aβ1–42/40 | 0.093 (0.010) | 0.088 (0.012) | 0.09 (0.01) | 0.044 (0.009)a | 0.042 (0.009)a | < 0.0001 | 0.091 (0.017) | 0.0879 (0.012) | 0.091 (0.017) | 0.049 (0.008)a | 0.043 (0.009)a | 0.043 (0.008)a | < 0.0001 |
CSF pTau, pg/mL | 32.25 (8.16) | 40.97 (20.81) | 33.59 (10.50) | 94.80 (47.31)a | 113.53 (60.02)a | < 0.0001 | 56.8 (31.4) | 50.2 (30.9) | 41.0 (24.4) | 59.1 (14.3) | 112 (59.6)a | 121.4 (57.9)a | < 0.0001 |
CSF t-tau, pg/mL | 236.62 (63.69) | 333,085 (172.630) | 362.26 (341.90) | 594.83 (285.45)a | 722.01 (393.87)a | < 0.0001 | 307 (141) | 357 (230) | 311 (166) | 407 (107) | 669 (323)a | 759 (342)a | < 0.0001 |
Biomarker profile | |||||||||||||
Normal profile | 21 (100%) | 39 (83%) | 25 (92%) | 0 (0%) | 0 (0%) | 9 (82%%) | 24 (86%) | 17 (89%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
AD continuum | 0 (0%) | 0 (0%) | 0 (0%) | 40 (100%) | 77 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 7 (100%) | 46 (100%) | 64 (100%) | ||
A+T− | / | / | / | 7 (18%) | 10 (13%) | / | / | / | 6 (86%) | 11 (24%) | 3 (5%) | ||
A+T+ | / | / | / | 33 (82%) | 67 (87%) | / | / | / | 1 (14%) | 35 (76%) | 61 (95%) | ||
SNAP | 0 (0%) | 8 (17%) | 2 (8%) | 0 (0%) | 0 (0%) | 2 (18%) | 4 (14%) | 2 (11%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
CSF p-tau biomarkers | |||||||||||||
CSF N-term p-tau181, pg/mL | 224.72 (66.33) | 300.708 (245.52) | 242.23 (110.58) | 965.91 (628.08) a | 1223.94 (802.66)a | < 0.0001 | 427 (110) | 410 (164) | 426 (168) | 494 (129) | 771 (257)a | 871 (343)a | < 0.0001 |
CSF N-term p-tau217, pg/mL | 1.84 (0.94) | 2.90 (2.50) | 2.14 (1.67) | 13.88 (9.48)a | 16.62 (9.74)a | < 0.0001 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CSF N-term p-tau231, pg/mL | 271.93 (64.74) | 325.05 (148.44) | 286.62 (114.72) | 657.64 (205.53)a | 800.58 (640.95)a | < 0.0001 | 313 (211) | 348 (201) | 331 (236) | 541 (144) | 788 (399)a | 893 (469)a | < 0.0001 |
CSF N-term p-tau235, pg/mL | 11.19 (2.94) | 12.74 (5.67) | 11.56 (4.30) | 24.75 (8.11)a | 28.03 (11.52)a | < 0.0001 | 17.6 (8.10) | 18.5 (11.3) | 17.4 (7.23) | 23.1 (3.65) | 34.8 (12.9)a | 41.6 (20.0)a | < 0.0001 |